Evan Bloch

Commentary
Commentary
03/07/2024
Michael J. Bloch, MD; Evan Bloch
In this commentary, Michael J. Bloch, MD, and Evan Bloch discuss the optimal approach to managing patients with hypertension in the United States, including using patients' self-measured blood pressure and...
03/07/2024
Commentary
Commentary
03/07/2024
Michael J. Bloch, MD; Evan Bloch
In this commentary, Michael J. Bloch, MD, and Evan Bloch discuss the optimal approach to managing patients with hypertension in the United States, including using patients' self-measured blood pressure and...
03/07/2024
Commentary
Commentary
01/19/2024
Evan Bloch; Michael J. Bloch, MD
In this article, Michael J. Bloch, MD, and Evan Bloch discuss the findings from the CARDIA-SSBP trial, which investigates the blood pressure responses to dietary sodium increase and decrease across a wide...
01/19/2024
Commentary
Commentary
01/19/2024
Evan Bloch; Michael J. Bloch, MD
In this article, Michael J. Bloch, MD, and Evan Bloch discuss the findings from the CARDIA-SSBP trial, which investigates the blood pressure responses to dietary sodium increase and decrease across a wide...
01/19/2024
Commentary
Commentary
02/09/2024
Michael J. Bloch, MD; Evan Bloch
In this article, Michael Bloch, MD, and Evan Bloch discuss findings from the SELECT trial, including the use of the glucagon-like peptide 1 receptor agonist, semaglutide, to reduce the risk of major...
02/09/2024
Commentary
Commentary
02/09/2024
Michael J. Bloch, MD; Evan Bloch
In this article, Michael Bloch, MD, and Evan Bloch discuss findings from the SELECT trial, including the use of the glucagon-like peptide 1 receptor agonist, semaglutide, to reduce the risk of major...
02/09/2024